Article Cited by others

INVITED ORIGINAL ARTICLE

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results

Kacker Ravi, Hult Mariam, San Francisco Ignacio F, Conners William P, Rojas Pablo A, Dewolf William C, Morgentaler Abraham

Year : 2016| Volume: 18| Issue : 1 | Page no: 16-20

   This article has been cited by
 
1 How the rise of testosterone therapy in men was inspired by lizard research with David Crews
Abraham Morgentaler
Journal of Experimental Zoology Part A: Ecological and Integrative Physiology. 2022; 337(1): 103
[Pubmed]  [Google Scholar] [DOI]
2 Androgens, aging, and prostate health
Karin Welén, Jan-Erik Damber
Reviews in Endocrine and Metabolic Disorders. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
Liuxun Li, Jiangli Xu
Clinical and Translational Oncology. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Safety of androgen therapy in men with prostate cancer
Mr Prabhakar Rajan, Tharu Tharakan, Runzhi Chen
Best Practice & Research Clinical Endocrinology & Metabolism. 2022; : 101628
[Pubmed]  [Google Scholar] [DOI]
5 Testosterone therapy in prostate cancer: is it still a controversy?
Alex S. Bart, Alexander Van Hoof, Ryan Badre-Hume, Joshua Selvarajah, Kristian Robillard, David M. Albala
Current Opinion in Urology. 2022; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
6 Updated Review of Testosterone Replacement Therapy in the Setting of Prostate Cancer
Michael Polchert,Igor Voznesensky,Ayman Soubra,Wayne J.G. Hellstrom
Androgens: Clinical Research and Therapeutics. 2021; 2(1): 36
[Pubmed]  [Google Scholar] [DOI]
7 Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations
Abraham Morgentaler,Alejandro Abello,Glenn Bubley
Androgens: Clinical Research and Therapeutics. 2021; 2(1): 121
[Pubmed]  [Google Scholar] [DOI]
8 Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?
Myong Kim, Seok-Soo Byun, Sung Kyu Hong
The World Journal of Men's Health. 2021; 39(4): 705
[Pubmed]  [Google Scholar] [DOI]
9 The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
Tao Xie,Xian-Lu Song,Chong Wang,Yu-Zhong Yu,Jing-Quan Wang,Zhe-Sheng Chen,Shan-Chao Zhao
Drug Discovery Today. 2021;
[Pubmed]  [Google Scholar] [DOI]
10 Terapia con testosterone nell’uomo con patologia benigna o maligna della prostata
Giulia Rastrelli, Mario Maggi, Linda Vignozzi
L'Endocrinologo. 2021; 22(2): 146
[Pubmed]  [Google Scholar] [DOI]
11 Trends in Testosterone Therapy use in Prostate Cancer Survivors in the United States
Tony Chen,Shufeng Li,Michael L. Eisenberg
The Journal of Sexual Medicine. 2021;
[Pubmed]  [Google Scholar] [DOI]
12 Recommandations pratiques pour la prise en charge du déficit en testostérone
C. Burte,H. Lejeune,A. Faix,P. Desvaux,T. Almont,B. Cuzin,E. Huyghe
Progrès en Urologie. 2021;
[Pubmed]  [Google Scholar] [DOI]
13 Déficit en testostérone. Quels bénéfices et risques et pour quels patients ?
A. Faix,B. Cuzin,P. Desvaux,E. Huyghe,H. Lejeune,T. Almond,C. Burté
Sexologies. 2021;
[Pubmed]  [Google Scholar] [DOI]
14 Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Bruno Lunenfeld,George Mskhalaya,Michael Zitzmann,Giovanni Corona,Stefan Arver,Svetlana Kalinchenko,Yuliya Tishova,Abraham Morgentaler
The Aging Male. 2021; 24(1): 119
[Pubmed]  [Google Scholar] [DOI]
15 Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer
Louis Lenfant,Priscilla Leon,Géraldine Cancel-Tassin,Marie Audouin,Frédéric Staerman,Morgan Rouprêt,Olivier Cussenot
Urologic Oncology: Seminars and Original Investigations. 2020;
[Pubmed]  [Google Scholar] [DOI]
16 Bipolar Androgen Therapy in Prostate Cancer (Update)
Eric M. Lo,Adithya Balasubramanian,Alexander W. Pastuszak,Mohit Khera
The Journal of Sexual Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
17 PICO: Testosteronsuppletie bij prostaatcarcinoom na curatieve behandeling of onder active surveillance
Jeroen Kolenburg,P. de Vries
Tijdschrift voor Urologie. 2020;
[Pubmed]  [Google Scholar] [DOI]
18 Strategies for Testosterone Therapy in Men with Metastatic Prostate Cancer in Clinical Practice: Introducing Modified Bipolar Androgen Therapy
Abraham Morgentaler
Androgens: Clinical Research and Therapeutics. 2020; 1(1): 76
[Pubmed]  [Google Scholar] [DOI]
19 Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
Jin Wook Kim
Investigative and Clinical Urology. 2020; 61(3): 242
[Pubmed]  [Google Scholar] [DOI]
20 Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
Abraham Morgentaler,Abdulmaged M. Traish
Investigative and Clinical Urology. 2020; 61(4): 452
[Pubmed]  [Google Scholar] [DOI]
21 Late-onset hypogonadism: Prostate safety
Eduardo P. Miranda,Luiz Otávio Torres
Andrology. 2020;
[Pubmed]  [Google Scholar] [DOI]
22 Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy
Thomas E. Ahlering,Linda My Huynh,Maxwell Towe,Kaelyn See,Joshua Tran,Kathryn Osann,Farouk M. el Khatib,Faysal A. Yafi
BJU International. 2020;
[Pubmed]  [Google Scholar] [DOI]
23 Reverse intermittent androgen deprivation therapy: Prostate cancer and hypopituitarism
George Hill, Raj Persad, Stefanos Bolomytis
Journal of Clinical Urology. 2020; : 2051415820
[Pubmed]  [Google Scholar] [DOI]
24 The effects of testosterone replacement therapy on the prostate: a clinical perspective
Saiful Miah,Tharu Tharakan,Kylie A Gallagher,Taimer T Shah,Mathias Winkler,Channa N Jayasena,Hashim U Ahmed,Suks Minhas
F1000Research. 2019; 8: 217
[Pubmed]  [Google Scholar] [DOI]
25 Investigating the basis of sexual dysfunction during late-onset hypogonadism
Tharu Tharakan,Saiful Miah,Channa Jayasena,Suks Minhas
F1000Research. 2019; 8: 331
[Pubmed]  [Google Scholar] [DOI]
26 Late-onset Hypogonadism and Testosterone Therapy – A Summary of Guidelines from the American Urological Association and the European Association of Urology
Mikkel Fode,Andrea Salonia,Suks Minhas,Arthur L. Burnett,Alan W. Shindel
European Urology Focus. 2019;
[Pubmed]  [Google Scholar] [DOI]
27 Testosterone Deficiency: A Review and Comparison of Current Guidelines
Jethro C.C. Kwong,Yonah Krakowsky,Ethan Grober
The Journal of Sexual Medicine. 2019;
[Pubmed]  [Google Scholar] [DOI]
28 Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine
Abraham Morgentaler,Abdulmaged Traish,Geoffrey Hackett,T. Hugh Jones,Ranjith Ramasamy
Sexual Medicine Reviews. 2019;
[Pubmed]  [Google Scholar] [DOI]
29 Testosterone, testosterone therapy and prostate cancer
A. Yassin,K. AlRumaihi,R. Alzubaidi,S. Alkadhi,A. Al Ansari
The Aging Male. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
30 Safety of testosterone therapy in men with prostate cancer
Abraham Morgentaler,Monica Caliber
Expert Opinion on Drug Safety. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
31 The History of Testosterone and the Evolution of its Therapeutic Potential
Abraham Morgentaler,Abdulmaged Traish
Sexual Medicine Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
32 Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis
Fiona Teeling,Mr Nicholas Raison,Mr Majed Shabbir,Mr Tet Yap,Professor Prokar Dasgupta,Mr Kamran Ahmed
Urology. 2018;
[Pubmed]  [Google Scholar] [DOI]
33 The Role of Testosterone Therapy in the Setting of Prostate Cancer
Katherine M. Rodriguez,Alexander W. Pastuszak,Mohit Khera
Current Urology Reports. 2018; 19(8)
[Pubmed]  [Google Scholar] [DOI]
34 Effects of Testosterone on Benign and Malignant Conditions of the Prostate
Amin S. Herati,Taylor P. Kohn,Peter R. Butler,Larry I. Lipshultz
Current Sexual Health Reports. 2017; 9(2): 65
[Pubmed]  [Google Scholar] [DOI]
35 Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth
Yonah Krakowsky,Abraham Morgentaler
European Urology Focus. 2017;
[Pubmed]  [Google Scholar] [DOI]
36 Testosterone Therapy in a Man with Intermediate-risk Prostate Cancer: Pro
Abraham Morgentaler
European Urology Focus. 2017;
[Pubmed]  [Google Scholar] [DOI]
37 Hypogonadism
John T. Sigalos,Alexander W. Pastuszak,Mohit Khera
Medical Clinics of North America. 2017;
[Pubmed]  [Google Scholar] [DOI]
38 Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer
Takeshi Hashimoto,Krishnan Rahul,Toshikazu Takeda,Nicole Benfante,John P. Mulhall,Hedvig Hricak,James A. Eastham,Hebert Alberto Vargas
Urologic Oncology: Seminars and Original Investigations. 2016;
[Pubmed]  [Google Scholar] [DOI]
39 Testosterone Therapy and Prostate Cancer
Emily Davidson,Abraham Morgentaler
Urologic Clinics of North America. 2016; 43(2): 209
[Pubmed]  [Google Scholar] [DOI]
40 Variation in Testosterone Levels and Health-related Quality of Life in Men Diagnosed With Prostate Cancer on Active Surveillance
Andrew Cohen,Brittany Lapin,Chi H. Wang,Brian Helfand,David Victorson,Kristian Novakovic
Urology. 2016;
[Pubmed]  [Google Scholar] [DOI]
41 Editorial Comment
Alan M. Nieder
Urology. 2016;
[Pubmed]  [Google Scholar] [DOI]
42 Testosterone Therapy Among Prostate Cancer Survivors
Taylor M. Nguyen,Alexander W. Pastuszak
Sexual Medicine Reviews. 2016;
[Pubmed]  [Google Scholar] [DOI]
43 Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes
Jesse Ory,Ryan Flannigan,Colin Lundeen,James G. Huang,Peter Pommerville,S. Larry Goldenberg
The Journal of Urology. 2016;
[Pubmed]  [Google Scholar] [DOI]
44 TEMPORARY REMOVAL: Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression
Abraham Morgentaler,Martin E. Gleave,Laurence Klotz
The Journal of Urology. 2016;
[Pubmed]  [Google Scholar] [DOI]
45 Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression
Martin E. Gleave,Laurence Klotz
The Journal of Urology. 2016;
[Pubmed]  [Google Scholar] [DOI]
46 Fundamental Concepts Regarding Testosterone Deficiency and Treatment
Abraham Morgentaler,Michael Zitzmann,Abdulmaged M. Traish,Anthony W. Fox,T. Hugh Jones,Mario Maggi,Stefan Arver,Antonio Aversa,Juliana C.N. Chan,Adrian S. Dobs,Geoffrey I. Hackett,Wayne J. Hellstrom,Peter Lim,Bruno Lunenfeld,George Mskhalaya,Claude C. Schulman,Luiz O. Torres
Mayo Clinic Proceedings. 2016; 91(7): 881
[Pubmed]  [Google Scholar] [DOI]
47 The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment.
Abraham Morgentaler,M. Zitzmann,A. M. Traish,A. W. Fox,T. H. Jones,M. Maggi,S. Arver,A. Aversa,J.C.N. Chan,A. S. Dobs,G. I. Hackett,W. J. Hellstrom,P. Lim,B. Lunenfeld,G. Mskhalaya,C. C. Schulman,L. O. Torres
Obesity and metabolism. 2016; 13(3): 15
[Pubmed]  [Google Scholar] [DOI]
48 Testosterone Therapy in Men With Prostate Cancer
Alan L. Kaplan,Jim C. Hu,Abraham Morgentaler,John P. Mulhall,Claude C. Schulman,Francesco Montorsi
European Urology. 2015;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article